Back to Search Start Over

Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign

Authors :
Eline Meyers
Liselore De Rop
Ellen Deschepper
Els Duysburgh
Tine De Burghgraeve
Pauline Van Ngoc
Marina Digregorio
Simon Delogne
Anja Coen
Nele De Clercq
Laëtitia Buret
Samuel Coenen
An De Sutter
Beatrice Scholtes
Jan Y. Verbakel
Piet Cools
Stefan Heytens
Source :
EUROPEAN JOURNAL OF GENERAL PRACTICE, The European journal of general practice
Publication Year :
2023
Publisher :
Informa UK Limited, 2023.

Abstract

BACKGROUND: Nursing home residents (NHR) and staff have been disproportionally affected by the COVID-19 pandemic and were therefore prioritised in the COVID-19 vaccination strategy. However, frail older adults, like NHR, are known to have decreased antibody responses upon vaccination targeting other viral antigens. OBJECTIVES: As real-world data on vaccine responsiveness, we assessed the prevalence of SARS-CoV-2 antibodies among Belgian NHR and staff during the primary COVID-19 vaccination campaign. METHODS: In total, we tested 1629 NHR and 1356 staff across 69 Belgian NHs for the presence of SARS-CoV-2 IgM/IgG antibodies using rapid tests. We collected socio-demographic and COVID-19-related medical data through questionnaires. Sampling occurred between 1 February and 24 March 2021, in a randomly sampled population that received none, one or two BNT162b2 vaccine doses. RESULTS: We found that during the primary vaccination campaign with 59% of the study population fully vaccinated, 74% had SARS-CoV-2 antibodies. Among fully vaccinated individuals only, fewer residents tested positive for SARS-CoV-2 antibodies (77%) than staff (98%), suggesting an impaired vaccine-induced antibody response in the elderly, with lowest seroprevalences observed among infection naïve residents. COVID-19 vaccination status and previous SARS-CoV-2 infection were predictors for SARS-CoV-2 seropositivity. Alternatively, age ≥ 80 years old, the presence of comorbidities and high care dependency predicted SARS-CoV-2 seronegativity in NHR. CONCLUSION: These findings highlight the need for further monitoring of SARS-CoV-2 immunity upon vaccination in the elderly population, as their impaired humoral responses could imply insufficient protection against COVID-19. TRIAL REGISTRATION: This study was retrospectively registered on ClinicalTrials.gov (NCT04738695). ispartof: EUROPEAN JOURNAL OF GENERAL PRACTICE vol:29 issue:2 ispartof: location:England status: published

Details

Language :
English
ISSN :
13814788 and 17511402
Database :
OpenAIRE
Journal :
EUROPEAN JOURNAL OF GENERAL PRACTICE, The European journal of general practice
Accession number :
edsair.doi.dedup.....dabd8997ca7c5cca710827bfd00c18bd